Skip to content

Clinical trials

Respiratory Distress Syndrome, Newborn trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome, Newborn Phase: Not applicable Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20092
20111
20123
20144
20152
20164
20177
20186
20191
20205
20212
20223
20233
20247
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Unknown status10
Terminated6
Recruiting5
Withdrawn3
Not yet recruiting3
Active, not recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University3
Rigshospitalet, Denmark3
Murdoch Childrens Research Institute2
University College Dublin2
University of Florence2
Aarhus University Hospital1
Aga Khan University1
Ahmadu Bello University Teaching Hospital1
Ain Shams University1
Arkansas Children's Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome, Newborn62
Premature Birth22
Respiratory Distress Syndrome10
Bronchopulmonary Dysplasia9
Pulmonary Atelectasis4
Lung Diseases3
Respiratory Aspiration3
Infant, Premature, Diseases2
Meconium Aspiration Syndrome2
Respiratory Insufficiency2

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.